Effectiveness of interventions to reduce contact rates during a simulated influenza pandemic

Emerging Infectious Diseases

Volumn 13, Issue 4, 2007, Pages 581-589

  Haber, Michael J ^a   Shay, David K ^b   Davis, Xiaohong M ^b   Patel, Rajan ^c   Jin, Xiaoping ^b   Weintraub, Eric ^b   Orenstein, Evan ^d   Thompson, William W ^b  

^a EMORY UNIVERSITY   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c AMGEN INC   (United States)

^d YALE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; DISEASE TRANSMISSION; HEALTH CARE FACILITY; HEALTH CARE PLANNING; INFECTION CONTROL; INFLUENZA; PANDEMIC; SIMULATION;

EID: 34047164461     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid1304.060828     Document Type: Article

References (20)

1. Patriarca PA, Cox NJ. Influenza pandemic preparedness plan for the United States. J Infect Dis. 1997;176(Suppl 1):S4-7.
2. Cox NJ, Tamblyn SE, Tam T. Influenza pandemic planning. Vaccine. 2003;21:1801-3.
3. Mounts AW, Kwong H, Izurieta HS, Ho Y, Au T, Lee M, et al. Case-control study of risk factors for avian influenza A (H5N1) disease, Hong Kong, 1997. J Infect Dis. 1999;180:505-8.
4. World Health Organization. Confirmed human cases of avian influenza A (H5N1) [cited 2005 Nov 15]. Available from http://www.who.int/csr/disease/ avian_influenza/country/en
5. Meltzer MI, Cox NJ, Fukuda K. The economic impact of pandemic influenza in the United States. Emerg Infect Dis. 1999;5:659-71.
6. Longini IM, Halloran ME, Nizam A, Yang Y. Containing pandemic influenza with antiviral agents. Am J Epidemiol. 2004;159:623-33.
7. United States Department of Health and Human Services Pandemic Influenza Plan. 2005. [cited 2005 Nov 15]. Available from http://www.hhs.gov/pandemicflu/ plan
8. Profiles of General Demographic Characteristics for the United States. 2000. [cited 2005 Nov 15]. Available from http://www. census.gov/census2000/ states/us.html
9. Thompson WW, Shay DK, Weintraub E, Brammer L, Cox N, Anderson LJ, et al. Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA. 2003;289:179-86.
10. Thompson WW, Shay DK, Weintraub E, Brammer L, Bridges CB, Cox NJ, et al. Influenza-associated hospitalizations in the United States. JAMA. 2004;292:1333-40.
11. Thompson WW, Weintraub E, Shay D, Brammer L, Cox N, Fukuda K. Estimation of influenza-associated deaths and hospitalizations in the United States. In: Osterhous ADME, Cox N, Hampson AW, editors. Options for the control of influenza IV. Philadelphia: Elsevier Science, International Congress Series; 2004. p. 316-20.
12. Mills CE, Robins JM, Lipsitch M. Transmissibility of 1918 pandemic influenza. Nature. 2004;432:904-6.
13. Longini IM, Nizam A, Xu S, Ungchusak K, Hanshaoworakul W, Cummings DA, et al. Containing pandemic influenza at the source. Science. 2005;309:1083-7.
14. Ferguson NM, Cummings DAT, Cauchemez S, Fraser C, Riley S, Meeyai A, et al. Strategies for containing an emerging influenza pandemic in Southeast Asia . Nature. 2005;437:209-14.
15. Longini IM, Halloran ME. Strategy for the distribution of influenza vaccine to high-risk groups and children. Am J Epidemiol. 2005;161:303-6.
16. Germann TC, Kadau K, Longini IM, Macken CA. Mitigation strategies for pandemic influenza in the United States. Proc Natl Acad Sci U S A. 2006;103:5935-40.
17. Carrat F, Luong J, Lao H, Salle AV, Lajaunie C, Wackernagel H, et al. A 'small-world-like' model for comparing interventions aimed at preventing and controlling influenza pandemics. BMC Med. 2006;4:26.
18. Bridges CB, Thompson WW, Meltzer MI, Reeve GR, Talamonti WJ, Cox NJ, et al. Effectiveness and cost-benefit of influenza vaccination of healthy working adults: a randomized controlled trial. JAMA. 2000;284:1655-63.
19. DiGiovanni C, Conley J, Chiu D, Zaborski J. Factors influencing compliance with quarantine in Toronto during the 2003 SARS outbreak. Biosecur Bioterror. 2004;2:265-72.
20. Centers for Disease Control and Prevention. Interim pre-pandemic planning guidance: community strategy for pandemic influenza mitigation in the United States-early, targeted, layered use of non-pharmaceutical intervention [cited 2007 Feb 2]. Available from http://www.pandemicflu.gov/plan/community/ mitigation.html